APA

Mäentausta O., Svalander P., Danielsson K. G., Bygdeman M. & Vihko R. (19931112). The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. : The Journal of clinical endocrinology and metabolism.

Chicago

Mäentausta O, Svalander P, Danielsson K G, Bygdeman M and Vihko R. 19931112. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. : The Journal of clinical endocrinology and metabolism.

Harvard

Mäentausta O., Svalander P., Danielsson K. G., Bygdeman M. and Vihko R. (19931112). The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. : The Journal of clinical endocrinology and metabolism.

MLA

Mäentausta O, Svalander P, Danielsson K G, Bygdeman M and Vihko R. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. : The Journal of clinical endocrinology and metabolism. 19931112.